Editorial: Ambiguous thyroglobulin assay results in the follow-up of differentiated thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 10, 2005, Pages 5904-5905

  Stockigt, Jim R ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN; BIOLOGICAL MARKER;

ANTIBODY DETECTION; BONE DENSITY; CANCER DIAGNOSIS; CANCER RISK; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; EDITORIAL; FOLLOW UP; HUMAN; IMMUNOASSAY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; ULTRASOUND; WHOLE BODY SCINTISCANNING; BLOOD; CARCINOMA; NOTE; REPRODUCIBILITY; THYROID TUMOR;

BIOLOGICAL MARKERS; CARCINOMA; HUMANS; IMMUNOASSAY; REPRODUCIBILITY OF RESULTS; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 26244446762     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1551     Document Type: Editorial

References (14)

1. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A 2003 A consensus report on the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433-1441
2. Torrens JI, Burch HB 2001 Serum thyroglobulin measurement; utility in clinical practice. Endocrinol Metab Clin North Am 30:429-467
3. Baudin E, Do Cao C, Cailleux AF, Leboulleux S, Travagli JP, Schlumberger M 2003 Positive predictive values of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal in thyroid cancer patients. J Clin Endocrinol Metab 88:1107-1111
4. Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C, Lippi F, Taddei D, Grasso L, Pinchera A 2003 Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 88:3668-3673
5. Feldt-Rassmussen U, Profilis C, Colinet E, Black E, Bornet H, Bourdoux P, Carayon P, Ericsson UB, Koutras DA, Lamas de Leon L, DeNayer P, Pacini F, Palumbo G, Santos A, Schlumberger M, Seidel C, Van Herle AJ, DeVijlder JJ 1996 Human thyroglobulin reference material (CRM 457). Physicochemical characterization and certification. Ann Biol Clin 54:343-348
6. Preissner CM, O'Kane DJ, Singh RJ, Morris JC, Grebe SK 2003 Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 88:3069-3074
7. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS, Nicoloff JT 1998 Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83:1121-1127
8. Mariotti S, Barbesino G, Caturegli P, Marino M, Manetti L, Pacini F, Centoni R, Pinchera A 1995 Assay of thyroglobulin in serum with thyroglobulin autoantibodies; an unobtainable goal? J Clin Endocrinol Metab 80:468-472
9. Van Herle AJ, Uller RP, Matthews NL, Brown J 1973 Radioimmunoassay for measurement of thyroglobulin in human serum. J Clin Invest 52:1320-1327
10. Schneider AB, Pervos R 1978 Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies. J Clin Endocrinol Metab 47:126-137
11. Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S, LoPresti JS 2005 Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 90:5566-5575
12. Yamamoto K, Tsuji T, Tarutani O, Osawa T 1984 Structural changes of carbohydrate chains of human thyroglobulin accompanying malignant transformation of thyroid glands. Eur J Biochem 143:133-144
13. Chung JK, Park YL, Kim TY, So Y, Kim S-K, Park DJ, Lee DS, Lee MC, Cho BY 2002 Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocrinol (Oxf) 57:215-221
14. Van Tool KM, Jager PL, Piers DA, Pruim J, de Vries EG, Dullaart RP, Links TP 2002 Better yield of (18) fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation. Thyroid 12:381-387